Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of the American College of Cardiology|November 1, 2005
Randomized evaluation of the TriActiv balloon-protection flush and extraction system for the treatment of saphenous vein graft diseaseJoseph P Carrozza, Michael Mumma, Jeffrey A Breall, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Correlates of adverse events during saphenous vein graft intervention with distal embolic protection: a PRIDE substudyAjay J Kirtane, Eugene R Heyman, Christopher Metzger, et al.
Clinical Pharmacology : Advances and Applications|June 29, 2016
Simultaneous administration of high-dose atorvastatin and clopidogrel does not interfere with platelet inhibition during percutaneous coronary interventionRolf P Kreutz, Jeffrey A Breall, Anjan Sinha, et al.
The Journal of Invasive Cardiology|July 5, 2011
Cardiac events after non-cardiac surgery in patients with previous coronary intervention in the drug-eluting stent eraIslam A Bolad, Ahmad Alqaqa'a, Bilal Khan, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 23, 2013
C-reactive protein and fibrin clot strength measured by thrombelastography after coronary stentingRolf P Kreutz, Janelle Owens, Jeffrey A Breall, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|March 19, 2019
Prediction of Ischemic Events after Percutaneous Coronary Intervention: Thrombelastography Profiles and Factor XIIIa ActivityRolf P Kreutz, Glen Schmeisser, Andrea Schaffter, et al.
Thrombosis Research|March 31, 2012
Protease activated receptor-1 (PAR-1) mediated platelet aggregation is dependent on clopidogrel responseRolf P Kreutz, Jeffrey A Breall, Yvonne Kreutz, et al.
Clinical Pharmacology : Advances and Applications|March 20, 2012
Influence of paraoxonase-1 Q192R and cytochrome P450 2C19 polymorphisms on clopidogrel responseRolf P Kreutz, Perry Nystrom, Yvonne Kreutz, et al.
Clinical Pharmacology : Advances and Applications|December 20, 2013
Cytochrome P450 3A4*22, PPAR-α, and ARNT polymorphisms and clopidogrel responseRolf P Kreutz, Janelle Owens, Yan Jin, et al.
Journal of Thrombosis and Thrombolysis|February 11, 2014
Factor XIII Val34Leu polymorphism and recurrent myocardial infarction in patients with coronary artery diseaseRolf P Kreutz, Abbas Bitar, Janelle Owens, et al.
Pageof 3